Clinical Trials, Industry, Research and Development, Vaccines
March 27, 2023
Via: Contract Pharma4Q Revenues: €4.3 billion (-23%) 4Q Earnings: €2.3 billion (-28%) YTD Revenues: €17.3 billion (-9%) YTD Earnings: €9.3 billion (-8%) Comments: Results in the quarter and FY reflect lower demand for COVID-19 vaccines. Approximately 2 billion doses of COMIRNATY invoiced […]
Clinical Trials, Research and Development
March 21, 2023
Via: Contract PharmaSyneos Health has entered a multi-year strategic agreement with Microsoft. Using Microsoft Azure services, Syneos Health has developed an advanced analytics platform designed to enable agile deployment of machine learning (ML) supporting the analysis, design and execution of clinical trials […]
Clinical Trials, Mergers and Acquisitions, Research and Development
March 10, 2023
Via: Contract PharmaLEO Pharma, a global leader in medical dermatology, and ICON plc, entered into a strategic partnership that will enable LEO Pharma to scale clinical trial execution that is patient-centric and cost effective, to support the company’s clinical portfolio. The partnership […]
Clinical Trials, Research and Development
March 6, 2023
Via: Biopharma DiveBased on the latest data, BridgeBio has started enrolling children in a Phase 3 trial of infigratinib in achondroplasia and also plans to develop the medicine for patients with a closely related skeletal abnormality known as hypochondroplasia. The company has […]
Clinical Trials, Research and Development
March 3, 2023
Via: Biopharma DiveIn spite of a setback, Praxis Precision Medicines, a Boston-based biotechnology company, plans to move its most advanced experimental drug into late-stage human testing. On Friday, Praxis said its drug, named ulixacaltamide, failed to meet the main goal of a […]
Clinical Trials, Research and Development
February 13, 2023
Via: Biopharma DiveA spinout of the Massachusetts Institute of Technology, Frequency sought to develop treatments for hearing loss by regenerating lost hair cells in the inner ear, rather than turning to hearing aids or implants. Both its lead drug FX-322 and FX-345, […]
Clinical Trials, Research and Development
February 13, 2023
Via: Biopharm InternationalPolicymakers and biopharma companies acknowledge the importance of assessing drugs and medical products on a wide range of ethnic and racial populations to fully understand medical effects on patients. This has bolstered support for studies to enroll patients in proportion […]
Clinical Trials, Research and Development
February 9, 2023
Via: World Pharma NewsGSK plc (LSE/NYSE: GSK) announced results from a retrospective study on clinical trial diversity, investigating the historical representation of US-based participants in GSK clinical trials. The study looked at clinical trial demographic data from 495 GSK and ViiV clinical trials […]
Clinical Trials, Mergers and Acquisitions, Research and Development
February 3, 2023
Via: Pharma TimesAardex Group – a company focused on remote research and healthcare adherence – and Cambridge Cognition have firmed a partnership up to provide monitoring during hybrid and decentralised clinical trials (DCTs). The link-up will involve the incorporation of Aardex’s MEMS […]
Clinical Trials, Industry, Research and Development, Vaccines
February 3, 2023
Via: World Pharma NewsA new way to significantly increase the potency of almost any vaccine has been developed by researchers from the International Institute for Nanotechnology (IIN) at Northwestern University. The scientists used chemistry and nanotechnology to change the structural location of adjuvants […]
Cell and Gene Therapy, Clinical Trials, Industry, Research and Development
January 31, 2023
Via: Biopharm InternationalBe The Match BioTherapies, a provider of solutions for developing and commercializing cell and gene therapies, in conjunction with the Center for International Blood and Marrow Transplant Research (CIBMTR), is offering expanded clinical research organization (CRO) services. These services are […]
Clinical Trials, Research and Development
January 26, 2023
Via: PharmaphorumMerck has said it will abandon the KEYNOTE-991 study of PD-1 inhibitor Keytruda (pembrolizumab) in patients with metastatic hormone-sensitive prostate cancer (mHSPC) after it showed no benefit on either overall survival (OS) or radiographic progression-free survival (rPFS) when the data […]
Clinical Trials, Research and Development
January 18, 2023
Via: PharmaphorumThe DNA of these so-called ‘genetic superheroes’ may contain clues about how to treat severe disease. By studying their natural resilience and using it to design new therapies, it could help so many people. However, the Resilience Project’s scientists had […]
Clinical Trials, Research and Development
January 17, 2023
Via: PharmaphorumUnify, launched in December 2020, is AstraZeneca’s patient app and clinical trial support tool. Already, it is operating at scale across the company, used in more than 28 countries and available in 62 languages. Dissecting heterogeneity To begin discussions, pharmaphorum […]
Clinical Trials, Research and Development
January 12, 2023
Via: PharmaphorumThe announcement marks the disappointing end of a marathon effort by Oramed to develop an oral insulin formulation for type 2 diabetes struggling to control blood sugar on standard therapies and as an alternative to injections. It exposes once again […]
Clinical Trials, Research and Development
January 9, 2023
Via: Biopharma DiveArrowhead’s drug, called fazirsiran, is designed to treat alpha-1 antitrypsin deficiency, a genetic condition in which a mutant form of the namesake protein accumulates in liver cells, causing fibrosis and cirrhosis. Alpha-1 antitrypsin, or AAT, deficiency has become a target […]
Clinical Trials, Research and Development
January 5, 2023
Via: PharmaphorumBioethics International has developed a benchmarking tool for “fair inclusion” in clinical trials, drawing on pivotal trials submitted to the FDA in support of 59 new cancer therapeutics – submitted by 25 sponsors – that were approved by the regulator […]
Clinical Trials, Research and Development
January 4, 2023
Via: PMLiVEThe start of the trial triggers a $5m milestone payment from AZ, which licensed AZD3152 from RQ Bio in May last year, and reinforces the financial position of the UK-based biotech to execute its four scientific programmes focused on viral […]
Clinical Trials, Research and Development
January 3, 2023
Via: Biopharma DiveThe biotechnology industry begins 2023 at a crossroads. In many ways, the sector is coming off of one of its toughest years in recent memory. Initial public offerings ground to a halt. A widely followed biotech stock index plunged nearly […]
Clinical Trials, Research and Development
January 3, 2023
Via: PharmaphorumHaemophilia is a rare genetic bleeding disorder that causes the blood to take a long time to clot because of a deficiency in one or several blood clotting factors. It is almost exclusively found in males. According to the World […]